Amneal Pharmaceuticals Inc (AMRX)

개요 뉴스 가격 이력 옵션 체인 토론 예측

Relative Volume:

Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile

Amneal Pharmaceuticals Inc

Healthcare (1143)

908-947-3120

400 Crossing Boulevard, 3rd Floor, Bridgewater

@amnealpharma

최신 SEC 제출 서류

AMRX's Discussions on Twitter

AMRX을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
AMRX Amneal Pharmaceuticals Inc	9.60	3.05B	2.68B	-184.45M	229.23M	-0.6805
ZTS Zoetis Inc	141.13	62.79B	9.39B	2.62B	2.22B	5.81
TAK Takeda Pharmaceutical Co Adr	14.65	47.25B	29.96B	957.25M	4.77B	0.304
HLN Haleon Plc Adr	8.72	39.56B	14.26B	1.98B	2.47B	0.4347
TEVA Teva Pharmaceutical Industries Ltd Adr	18.36	22.11B	16.70B	-157.13M	1.19B	-0.155
UTHR United Therapeutics Corp	425.42	19.84B	2.99B	1.21B	1.13B	25.06

Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-06-06	개시	Goldman	Buy
2025-02-24	업그레이드	JP Morgan	Neutral → Overweight
2024-09-06	업그레이드	JP Morgan	Underweight → Neutral
2021-04-07	재개	RBC Capital Mkts	Sector Perform
2021-03-08	업그레이드	Goldman	Sell → Buy
2020-12-14	업그레이드	Barclays	Equal Weight → Overweight
2020-12-14	업그레이드	Guggenheim	Neutral → Buy
2020-07-27	개시	Goldman	Sell
2020-05-12	업그레이드	Guggenheim	Sell → Neutral
2019-12-12	다운그레이드	Raymond James	Outperform → Mkt Perform
2019-11-12	다운그레이드	JP Morgan	Neutral → Underweight
2019-11-07	다운그레이드	SVB Leerink	Outperform → Mkt Perform
2019-07-22	업그레이드	SVB Leerink	Mkt Perform → Outperform
2019-07-11	다운그레이드	RBC Capital Mkts	Outperform → Sector Perform
2019-07-08	업그레이드	Piper Jaffray	Neutral → Overweight
2019-06-11	개시	Barclays	Equal Weight
2019-05-21	업그레이드	Raymond James	Mkt Perform → Strong Buy
2019-03-20	개시	SunTrust	Buy
2019-03-08	다운그레이드	SVB Leerink	Outperform → Mkt Perform
2018-12-14	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2018-10-16	다운그레이드	SunTrust	Buy → Hold
2018-08-13	업그레이드	RBC Capital Mkts	Sector Perform → Outperform
2018-07-23	개시	Morgan Stanley	Overweight
2018-06-22	개시	B. Riley FBR, Inc.	Buy

Amneal Pharmaceuticals Inc 주식(AMRX)의 최신 뉴스

Amneal Pharmaceuticals Inc (AMRX) 재무 분석

Amneal Pharmaceuticals Inc (AMRX)

Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile

AMRX을(를) 다른 주식과 비교

Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades

Amneal Pharmaceuticals Inc 주식(AMRX)의 최신 뉴스

Amneal Pharma Stock Rises On FDA Approval For Generic Version Of AbbVie’s Eyedrops - MSN

FDA approves Amneal's bimatoprost 0.01% generic - Eyes On Eyecare

A Look at Amneal Pharmaceuticals's Valuation Following FDA Approval of Generic LUMIGAN - Yahoo Finance

Amneal Pharmaceuticals Positioned for Significant Growth with Strong Product Momentum and Strategic Advantages - TipRanks

FDA approves Amneal’s generic bimatoprost for glaucoma treatment - Investing.com

Amneal Pharmaceuticals receives FDA approval for bimatoprost ophthalmic solution - TipRanks

Amneal Receives U.S. FDA Approval for Bimatoprost Ophthalmic Solution, 0.01% - GlobeNewswire

$685M Market Opportunity: Amneal's Generic Glaucoma Treatment Gets FDA Green Light for Patient Care - Stock Titan

Parkinson's Disease Therapeutics Market Size to Hit US$ 12.83 Billion by 2033, Report by DataM Intelligence - Yahoo Finance

AMNEAL PHARMACEUTICALS (NASDAQ:AMRX) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - MarketBeat

AMNEAL PHARMACEUTICALS, INC. (NASDAQ:AMRX) Receives $12.00 Average PT from Analysts - MarketBeat

Whats the fair value of Amneal Pharmaceuticals Inc stockJuly 2025 PreEarnings & Smart Money Movement Alerts - خودرو بانک

Goldman Sachs Group Inc. Sells 36,556 Shares of AMNEAL PHARMACEUTICALS, INC. $AMRX - MarketBeat

Tech Rally: Does Amneal Pharmaceuticals Inc stock have upside surprise potentialQuarterly Profit Report & Short-Term High Return Ideas - خودرو بانک

Caxton Associates LLP Takes $339,000 Position in AMNEAL PHARMACEUTICALS, INC. $AMRX - MarketBeat

FDA Accepts New Drug Application for Parkinson’s Disease Treatment - Docwire News

Stop Loss: Is Amneal Pharmaceuticals Inc a potential multi baggerJuly 2025 Analyst Calls & High Accuracy Swing Trade Signals - خودرو بانک

AQR Capital Management LLC Boosts Stake in AMNEAL PHARMACEUTICALS, INC. $AMRX - MarketBeat

Excessive Daytime Sleepiness Pipeline Insight 2025: Amneal’s FDA Approval of Sodium Oxybate Oral Solution, Novel Orexin Agonists, and Next-Generation Sleep-Wake Modulators Redefine Narcolepsy Care | D - Barchart.com

Amneal expects to meet or top annual guidance - MSN

Jones Financial Companies Lllp Takes $1.73 Million Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat

Excessive Daytime Sleepiness Pipeline Insight 2025: Amneal's - openPR.com

Woodline Partners LP Has $12.60 Million Stock Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat

Is Amneal Pharmaceuticals Inc in a long term uptrend2025 Year in Review & Stepwise Entry and Exit Trade Signals - خودرو بانک

Acadian Asset Management LLC Has $21.76 Million Stock Holdings in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat

Aug Rallies: Can Amneal Pharmaceuticals Inc continue delivering strong returns2025 Momentum Check & Target Return Focused Picks - خودرو بانک

Analyst Downgrade: What are the future prospects of Amneal Pharmaceuticals Inc2025 Key Highlights & Weekly High Momentum Picks - خودرو بانک

Aug Big Picture: Does Amneal Pharmaceuticals Inc. have pricing powerGap Up & Weekly Top Performers Watchlists - خودرو بانک

Portfolio Update: Can Amneal Pharmaceuticals Inc continue delivering strong returnsEarnings Overview Summary & Risk Controlled Swing Alerts - خودرو بانک

Aug Final Week: Is Amneal Pharmaceuticals Inc stock undervalued right nowQuarterly Profit Summary & Daily Growth Stock Investment Tips - خودرو بانک

Nasdaq Moves: Is Amneal Pharmaceuticals Inc forming a double bottomQuarterly Trade Report & Long-Term Capital Growth Strategies - خودرو بانک

Amneal secures FDA approval for sodium oxybate solution - World Pharmaceutical Frontiers

Aug Outlook: Can Amneal Pharmaceuticals Inc continue delivering strong returnsWeekly Profit Recap & Consistent Profit Alerts - خودرو بانک

Amneal Pharmaceuticals (NASDAQ:AMRX) Hits New 52-Week HighShould You Buy? - MarketBeat

Amneal receives FDA approval of treatment for narcoleptic sufferers - ROI-NJ

Ophthalmic Packaging Market Worth USD 23.65 Billion by 2034 | Towards Packaging - GlobeNewswire Inc.

Ieq Capital LLC Takes $288,000 Position in AMNEAL PHARMACEUTICALS, INC. $AMRX - MarketBeat

Why Amneal (AMRX) Stock Is Up Today - Yahoo Finance

Amneal wins FDA nod for generic targeting Jazz Pharma’s Xyrem - Seeking Alpha

Amneal Pharmaceuticals Wins US FDA Approval for Generic Version of Narcolepsy Drug Xyrem - MarketScreener

Amneal receives US FDA approval of Sodium Oxybate Oral Solution - MarketScreener

Amneal Receives U.S. FDA Approval of Sodium Oxybate Oral Solution - GlobeNewswire

150,000 Narcolepsy Patients Get New Option: Amneal's FDA-Approved Generic Breaks Single-Maker Market - Stock Titan

Amneal Pharmaceuticals: A Large, Diversified Clinical Portfolio That Keeps Growing (AMRX) - Seeking Alpha

Amylyx, Amneal, And Argenx Hit 52-Week Highs Amid Drug Pipeline Momentum And Strategic Catalysts - Nasdaq

Amneal Pharmaceuticals, Inc. $AMRX Shares Bought by Raymond James Financial Inc. - MarketBeat

Amneal Pharmaceuticals Inc (AMRX) 재무 분석

매출

순이익

현금흐름

주당 순 이익

AMRX과 유사한 종목